Skip to main content

Sulfaquinoxaline

ADVERTISEMENT
Identification
Molecular formula
C14H12N4O4S
CAS number
59-40-5
IUPAC name
3-[hydroxy-[(5-methylisoxazol-3-yl)amino]methylene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one
State
State

At room temperature, sulfaquinoxaline is typically found in a solid state as a powder.

Melting point (Celsius)
250.00
Melting point (Kelvin)
523.15
Boiling point (Celsius)
800.00
Boiling point (Kelvin)
1 073.15
General information
Molecular weight
300.34g/mol
Molar mass
300.3400g/mol
Density
1.5610g/cm3
Appearence

Sulfaquinoxaline appears as a white or slightly yellow crystalline powder. It is generally odorless.

Comment on solubility

Solubility of 3-[hydroxy-[(5-methylisoxazol-3-yl)amino]methylene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one

The solubility of the compound with the formula C14H12N4O4S can be influenced by several factors, given its complex structure. Understanding its behavior in different solvents is crucial for its application.

Factors Affecting Solubility

  • Polarity: The presence of polar groups such as hydroxyl (–OH) may enhance solubility in polar solvents like water.
  • Molecular Interactions: The compound may engage in hydrogen bonding, which can affect its solubility. This is particularly significant in aqueous environments.
  • Structural Considerations: The overall hydrophobicity or hydrophilicity of the compound will play an essential role. In this case, the presence of the benzothiazine moiety could lead to varying solubility based on its interactions.
  • pH of the Environment: Solubility may also vary with changes in pH, especially with compounds that can ionize.

In summary, the solubility of this compound may be expected to vary significantly between different solvents due to its unique functional groups and overall structure. Researchers and practitioners should consider conducting specific solubility tests in a range of conditions to fully understand its potential applications.

Interesting facts

Interesting Facts about 3-[hydroxy-[(5-methylisoxazol-3-yl)amino]methylene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one

This intriguing compound, a member of the benzothiazine family, has garnered attention for its potential biological activity. Research suggests that compounds like this one could possess properties beneficial to drug development, particularly in the fight against various diseases.

Key Highlights:

  • Complex Structure: Its multifaceted structure features a benzothiazine core, which is often linked to pharmacologically active compounds.
  • Isoxazole Integration: The inclusion of a 5-methylisoxazol-3-yl group enhances its biological efficacy, as isoxazoles are known for their anti-inflammatory and antimicrobial properties.
  • Hydroxyl and Methylene Groups: The hydroxy and methylene functionalities are crucial in facilitating interactions with biological targets, potentially leading to novel therapeutic applications.
  • Research Potential: Ongoing studies are focused on understanding how alterations in its structure can influence its biological activity, making it a valuable compound for medicinal chemists.

As researchers strive to explore its implications, this compound stands as a perfect illustration of how chemical diversity can lead to exciting opportunities in drug discovery. The confluence of various properties within its structure embodies a lot of potential, making it a subject of particular interest in the realm of pharmaceuticals.

In conclusion, the future of 3-[hydroxy-[(5-methylisoxazol-3-yl)amino]methylene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one is promising, as scientists continue to peel back the layers of its complex chemistry to unlock new realms of medicinal potential.